Cargando…
Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione
The major risk factor for melioidosis, an infectious disease caused by B. pseudomallei, is diabetes mellitus. More than half of diabetic melioidosis patients in Thailand were prescribed glibenclamide. Recent evidence demonstrates that glibenclamide reduces pro-inflammatory cytokine production by pol...
Autores principales: | Kewcharoenwong, Chidchamai, Rinchai, Darawan, Nithichanon, Arnone, Bancroft, Gregory J., Ato, Manabu, Lertmemongkolchai, Ganjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054430/ https://www.ncbi.nlm.nih.gov/pubmed/27713554 http://dx.doi.org/10.1038/srep34794 |
Ejemplares similares
-
Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei
por: Kessler, Bianca, et al.
Publicado: (2017) -
Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection
por: Kewcharoenwong, Chidchamai, et al.
Publicado: (2013) -
Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocytes
por: Nithichanon, Arnone, et al.
Publicado: (2020) -
Immune Control of Burkholderia pseudomallei––Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes
por: Nithichanon, Arnone, et al.
Publicado: (2018) -
Evaluation of plasma anti-GPL-core IgA and IgG for diagnosis of disseminated non-tuberculous mycobacteria infection
por: Nithichanon, Arnone, et al.
Publicado: (2020)